Morgan Cheatham is a Vice President with Bessemer Venture Partners where he spearheads healthcare and life sciences investments from seed to growth stages. He focuses across the healthcare and life sciences value chain spanning services, software, diagnostics, and therapeutics, and specializes in applications of computation in improving patient care from bench to bedside. Several of Morgan’s early-stage investments have eclipsed multi-billion dollar valuations and have been honored as Time100 Most Influential Companies, and include Hinge Health, Headspace Health, Groups, FOLX Health (where he serves as ...read more